pre-seed
Stage
1
Investors
About
ImmunoMind develops AI-driven solutions to analyze immune system data for advancing cancer and immunotherapy research.
Explore ImmunoMind's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.